Fibromyalgia & musculoskeletal pain

Chronic musculoskeletal pain among Ebola survivors in Guinea: a cross-sectional study reveals key risk factors and the need for specialized care

Rheumatology (Oxford)Published Cross-sectional study

Authors' conclusion

Joint and muscle pain sequelae are frequent and require specialized care.

Study context

Population
Survivors of the 2013–16 West African Ebola virus disease (EVD) outbreak in the PostEboGui cohort, Conakry district, Guinea (55.6% female; median age 28.2 years)55.6% female
Participants
313 survivors
Exposure
Ebola survivors vs seronegative controls living in the same area
  • Ebola survivorsn = 313
Outcome
Chronic musculoskeletal pain
Methodological detailssystematic rheumatological screening, regression models, seronegative control cohort
  • Systematic rheumatological screening
  • Regression models
  • Seronegative control cohort

Main finding

As reported in the abstract

Chronic MS pain

Chronic musculoskeletal (MS) pain reported among the 313 patients, n (%)

216

69%

Previous Ebola infection as risk factor for chronic MS pain vs seronegative control cohort, aOR

6.66

95% CI 4.52–9.92

Observational data: associations, not effects.

Further findings

Enthesis and painful peripheral joints involved, among patients with chronic MS pain

Enthesis and painful peripheral joints largely involved, n (%)
196 (91%)
  • Symmetrical distribution

Risk factors for current MS pain among survivors

Increasing age, OR
1.14 (95% CI 1.08-1.22)
Female gender, OR
3.58 (95% CI 1.22-11.80)
Myalgia during acute phase of EVD (appeared protective), OR
0.14 (95% CI 0.04-0.42)

Time from Ebola Treatment Centre (ETC) discharge to rheumatological visit

Median time from ETC discharge to rheumatological visit, months (IQR 23-30)
26.2

Original publication

Chronic musculoskeletal pain among Ebola survivors in Guinea: a cross-sectional study reveals key risk factors and the need for specialized care. Rheumatology (Oxford). Published 18 April 2025. doi:10.1093/rheumatology/keaf212

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.